Frenzen Paul D, Drake Alison, Angulo Frederick J
Economic Research Service, U.S. Department of Agriculture, 1800 M Street N.W., Washington, DC 20036-5831, USA.
J Food Prot. 2005 Dec;68(12):2623-30. doi: 10.4315/0362-028x-68.12.2623.
The Centers for Disease Control and Prevention (CDC) has estimated that Shiga toxin-producing Escherichia coli O157 (0157 STEC) infections cause 73,000 illnesses annually in the United States, resulting in more than 2,000 hospitalizations and 60 deaths. In this study, the economic cost of illness due to O157 STEC infections transmitted by food or other means was estimated based on the CDC estimate of annual cases and newly available data from the Foodborne Diseases Active Surveillance Network (FoodNet) of the CDC Emerging Infections Program. The annual cost of illness due to O157 STEC was $405 million (in 2003 dollars), including $370 million for premature deaths, $30 million for medical care, and $5 million in lost productivity. The average cost per case varied greatly by severity of illness, ranging from $26 for an individual who did not obtain medical care to $6.2 million for a patient who died from hemolytic uremic syndrome. The high cost of illness due to O157 STEC infections suggests that additional efforts to control this pathogen might be warranted.
美国疾病控制与预防中心(CDC)估计,产志贺毒素大肠杆菌O157(O157 STEC)感染每年在美国导致7.3万例疾病,造成2000多人住院,60人死亡。在本研究中,基于CDC对年度病例的估计以及CDC新发传染病项目食源性疾病主动监测网络(FoodNet)的最新数据,对由食物或其他途径传播的O157 STEC感染所致疾病的经济成本进行了估算。O157 STEC所致疾病的年度成本为4.05亿美元(按2003年美元计算),其中包括3.7亿美元的过早死亡成本、3000万美元的医疗护理成本以及500万美元的生产力损失成本。每例病例的平均成本因疾病严重程度差异很大,从未接受医疗护理者的26美元到死于溶血性尿毒症综合征患者的620万美元不等。O157 STEC感染所致疾病的高成本表明,或许有必要进一步努力控制这种病原体。